New York State Psychiatric Institute: Cocaine-Related Disorders trials

The registry lists 31 Cocaine-Related Disorders studies with New York State Psychiatric Institute as lead sponsor. 1 are open to participants now and 19 have results posted.

Phase 1 5Phase 2 26Phase 3 7Phase 4 1No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• rTMS and Cognitive-behavioral Therapy for Cocaine Use DisorderRecruitingNCT05974202Not applicable
• The Effect of Glutamatergic Modulation on Cocaine Self-administrationCompletedNCT02596022Phase 2Results posted
• Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.CompletedNCT02255357Phase 2/3Results posted
• A Sequenced Behavioral and Medication Intervention for Cocaine DependenceCompletedNCT01986075Phase 1/2Results posted
• Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine DependenceCompletedNCT01811940Phase 2/3Results posted
• Glutamatergic Modulation of Cocaine-related DeficitsCompletedNCT01790490Phase 2Results posted
• Modafinil for Smoked Cocaine Self-AdministrationCompletedNCT01778010Phase 2Results posted
• The Effect of Brief Potent Glutamatergic Modulation on Cocaine DependenceTerminatedNCT01535937Phase 1/2Results posted
• Open-Label Pilot Study of Lisdexamfetamine for Cocaine DependenceCompletedNCT01486810Phase 1/2Results posted
• Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine DependenceCompletedNCT01468012Phase 2/3Results posted
• Investigation of Mifepristone (RU486) on Stress Sensitivity and Relapse Prevention in Cocaine Dependent PatientsCompletedNCT01134198Phase 2/3Results posted
• Therapeutic Cocaine Vaccine: Human Laboratory StudyCompletedNCT00965263Phase 2Results posted
• Progesterone Treatment for Cocaine-dependent Women: A Pilot StudyCompletedNCT00632099Phase 2/3Results posted
• Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine DependenceCompletedNCT00553319Phase 2/3Results posted
• A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine DependenceCompletedNCT00421603Phase 2Results posted
• Imaging the Neurobiology of a Behavioral Treatment for Cocaine DependenceCompletedNCT00376558Not applicableResults posted
• Effects of Aripiprazole on Cocaine Craving and Self-AdministrationCompletedNCT00373880Phase 2Results posted
• Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From DepressionCompletedNCT00249444Phase 2Results posted
• Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00218543Phase 2Results posted
• Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2CompletedNCT00134901Phase 2Results posted
• Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)CompletedNCT01437293Phase 1
• Effects of Vigabatrin on Cocaine Self-AdministrationTerminatedNCT00373581Phase 2
• Venlafaxine to Reduce Cocaine Dependence in Depressed IndividualsCompletedNCT00249483Phase 2
• Methylphenidate Treatment for Cocaine Abuse and ADHD - 1CompletedNCT00136734Phase 1
• Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1CompletedNCT00061087Phase 2/3
• Early Phase II Trials for Cocaine Medication Development - 1CompletedNCT00000317Phase 2
• New Approaches to Cocaine Abuse Medications (A) - 6CompletedNCT00000271Phase 2
• Brain Imaging: Cocaine Effects & Medication Development - 5WithdrawnNCT00000270Phase 4
• IV Cocaine Abuse: A Laboratory Model - 3CompletedNCT00000214Phase 2
• IV Cocaine Abuse: A Laboratory Model - 2CompletedNCT00000213Phase 2
• IV Cocaine Abuse: A Laboratory Model - 1CompletedNCT00000212Phase 2